JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 9, 2006; DOI: 10.1124/jpet.106.106120


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.106120v1
318/3/1257    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ko, M.C. H.
Right arrow Articles by Kennedy, R. T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ko, M.C. H.
Right arrow Articles by Kennedy, R. T


Received for publication April 13, 2006.
Revised June 7, 2006.
Accepted for publication June 8, 2006.

Effects of Intrathecally Administered Nociceptin/Orphanin FQ in Monkeys: Behavioral and Mass Spectrometric Studies

M.C. Holden Ko 1*, Hui Wei 2, James H Woods 1, Robert T Kennedy 2

1 University of Michigan, Dept. of Pharmacology 2 University of Michigan, Dept. of Chemistry

* Address correspondence to: E-mail: mko{at}umich.edu

Abstract

Nociceptin/Orphanin FQ (N/OFQ) is a heptadecapeptide that is an endogenous ligand for the NOP receptor. The aim of this study was to investigate the behavioral responses of N/OFQ and its major fragment N/OFQ(2-17) in monkeys following intrathecal (i.t.) administration. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) was used to quantify the amounts of N/OFQ and N/OFQ(2-17) in the cerebrospinal fluid at specific time points when effects of i.t. N/OFQ were sustained and disappeared. I.t. administration of N/OFQ dose-dependently (10-100 nmol) produced long-lasting antinociception against a noxious stimulus, 50 °C water, and did not elicit itch/scratching responses in monkeys. Subcutaneous pretreatment with a selective NOP receptor antagonist, (+)J-113397 (0.1 mg/kg), completely blocked i.t. N/OFQ (100 nmol)-induced antinociception. In contrast, a classical opioid receptor antagonist, naltrexone (0.01 and 1 mg/kg), failed to reverse i.t. N/OFQ-induced antinociception. MALDI-TOFMS showed that the amount of N/OFQ(2-17) was 4-fold higher than that of N/OFQ at 1.5 h after i.t. administration of 100 nmol N/OFQ. I.t. N/OFQ-induced antinociception disappeared at 4.5 h which corresponded to nearly undetectable cerebrospinal fluid levels of N/OFQ. No other metabolite of N/OFQ was detected at appreciable levels at either the 1.5- or 4.5-h time points. Although significant amounts of N/OFQ(2-17) were detected at the 1.5- and 4.5-h time points, i.t. N/OFQ(2-17) 100 nmol was inactive in changing the monkeys' nociceptive threshold. These results provide the first functional evidence of spinal N/OFQ-induced antinociception in primates and indicate that activation of spinal NOP receptors may be a potential target for spinal analgesics.


Key words: analgesics, mass spectrometry, monkeys, opioid receptors, orphanin FQ, spinal





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.